Cambrian BioPharma
Biotechnology company developing transformative medicines for aging-related diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€364—545m (Dealroom.co estimates Oct 2021.)
New York City New York (HQ)
Authorizing premium user...